{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:03:09Z","timestamp":1762898589419},"reference-count":26,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2009,4,24]],"date-time":"2009-04-24T00:00:00Z","timestamp":1240531200000},"content-version":"vor","delay-in-days":3950,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European J of Haematology"],"published-print":{"date-parts":[[1998,7]]},"abstract":"<jats:p><jats:bold>Abstract: <\/jats:bold> We have evaluated the number and differentiation pattern of CD34+ cells, as well as the CFU\u2013GM, BFU\u2013E and CFU\u2013GEMM progenitors from the blood (PB) and marrow (BM) of 53 chronic lymphocytic leukaemia (CLL) patients. Twenty\u2010four patients were untreated and 29 were studied at 2 months from the last course of fludarabine or chlorambucil; 6 patients, studied after fludarabine therapy, were further evaluated after mobilization with cyclophosphamide and G\u2013CSF. PB of untreated patients showed a median number of CD34+ cells, CFU\u2013GM, BFU\u2013E and CFU\u2013GEMM\/10<jats:sup>5<\/jats:sup> seeded cells and per litre of PB similar to those of normal controls. No differences were also found in the number of clonogenic progenitors\/10<jats:sup>5<\/jats:sup> cells in patients studied before and after therapy, while significantly fewer BFU\u2013E\/l of PB were found after fludarabine. The number of circulating CD34+ cells\/l of PB was significantly lower in patients treated with fludarabine or chlorambucil compared to untreated patients. BM growth was significantly reduced in untreated CLL patients compared to healthy donors. Treatment with fludarabine or chlorambucil restored BM progenitors at levels similar to those of normal controls; this effect did not occur for CFU\u2013GM in patients treated with fludarabine. Three\u2010colour fluorescence analysis demonstrated a differentiation pattern of CD34+ cells, with a greater expression of CD13 and CD33 after treatment with fludarabine compared to untreated patients and normal controls. In 4 patients previously treated with fludarabine who underwent a successful cyclophosphamide and G\u2010CSF mobilization therapy, 4 \u00d7 10<jats:sup>6<\/jats:sup> CD34+ cells\/kg were collected. These 4 patients showed a notable increase of CD34+ cells and of clonogenic cells in the PB, but a marked decrease of BM progenitor cells. The 2 patients who failed CD34+ cell mobilization had a reduced CFU\u2010GM growth both in the PB and in the BM. Taken together, these studies indicate that residual haemopoietic progenitors are present in untreated CLL patients and that stem cell mobilization and collection can be carried out following fludarabine treatment.<\/jats:p>","DOI":"10.1111\/j.1600-0609.1998.tb01055.x","type":"journal-article","created":{"date-parts":[[2010,7,18]],"date-time":"2010-07-18T09:19:36Z","timestamp":1279444776000},"page":"14-20","source":"Crossref","is-referenced-by-count":17,"title":["Evaluation of marrow and blood haemopoietic progenitors in chronic lymphocytic leukaemia before and after chemotherapy"],"prefix":"10.1111","volume":"61","author":[{"given":"Roberta","family":"Sala","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca R.","family":"Mauro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Bellucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Stefania","family":"De Propris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iole","family":"Cordone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Lisci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin","family":"Fo\u00e0","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"De Fabritiis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,4,24]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1182\/blood.V50.6.1049.1049","article-title":"Comparison of daily versus intermittent chlorambucil and prednisone therapy in the treatment of patients with chronic lymphocytic leukemia","volume":"50","author":"Sawitsky A.","year":"1977","journal-title":"Blood"},{"key":"e_1_2_1_3_2","first-page":"457","article-title":"Fludarabine monophosphate: A potentially useful agent in chronic lymphocytic leukemia","volume":"30","author":"Grever MR","year":"1988","journal-title":"New Rev Fr Hematol"},{"key":"e_1_2_1_4_2","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1182\/blood.V82.6.1695.1695","article-title":"Results of fludarabine and prednisone therapy in 264 patients with chronic lymphocytic leukemia with multivariate analysis derived prognostic model for response to treatment","volume":"82","author":"O'Brien S.","year":"1993","journal-title":"Blood"},{"key":"e_1_2_1_5_2","first-page":"49","article-title":"Fludarabine phosphate in the treatment of chronic lymphocytic leukemia","volume":"17","author":"Keating MJ.","year":"1990","journal-title":"Semin Oncol"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V80.1.29.29"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1995.tb00677.x"},{"key":"e_1_2_1_8_2","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1600-0609.1996.tb01358.x","article-title":"CFU\u2013GM are not increased in peripheral blood of patients with chronic lymphocytic leukaemia","volume":"57","author":"Scalzulli PR","year":"1996","journal-title":"Eur J Haematol"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-110-3-236"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19810701)48:1<198::AID-CNCR2820480131>3.0.CO;2-V"},{"key":"e_1_2_1_11_2","first-page":"359","article-title":"Natural history of chronic lymphocytic leukemia: on the progression and prognosis of early clinical stages","volume":"30","author":"Montserrat E.","year":"1988","journal-title":"Nouv Rev Fr Hematol"},{"key":"e_1_2_1_12_2","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1182\/blood.V69.3.929.929","article-title":"Talpaz M. Prognosis of chronic lymphocytic leukemia: a multivariate regression analysis of 325 untreated patients","volume":"69","author":"Lee JS","year":"1987","journal-title":"Blood"},{"key":"e_1_2_1_13_2","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1182\/blood.V78.6.1545.1545","article-title":"Presenting features and prognosis of chronic lymphocytic leukemia in younger adults","volume":"78","author":"Montserrat E.","year":"1991","journal-title":"Blood"},{"key":"e_1_2_1_14_2","first-page":"2353","article-title":"Inhibition of UV\u2010induced DNA repair in quiescent human peripheral blood lymphocytes by fludarabine stimulates apoptosis","volume":"35","author":"Sandoval A.","year":"1994","journal-title":"Proc Am Assoc Cancer Res"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00685844"},{"key":"e_1_2_1_16_2","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1182\/blood.V81.11.2878.2878","article-title":"Long\u2010term follow up in patients with chronic lymphocytic leukemia treated with fludarabine as single agent","volume":"81","author":"Keating MJ","year":"1993","journal-title":"Blood"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V74.1.19.bloodjournal74119"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1991.9.1.44"},{"key":"e_1_2_1_19_2","first-page":"275","article-title":"Allogeneic bone marrow transplantation in chronic lymphocytic leukemia: 17 cases. Report from the EBMTG","volume":"7","author":"Michallet M.","year":"1991","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_1_20_2","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1182\/blood.V82.4.1366.1366","article-title":"Autologous and allogenic bone marrow transplantation for poor prognosis patients with B\u2010cell chronic lymphocytic leukemia","volume":"82","author":"Rabinowe SN","year":"1993","journal-title":"Blood"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1994.12.4.748"},{"key":"e_1_2_1_22_2","first-page":"55","article-title":"Hematopoietic stem cell transplant for chronic lymphocytic leukemia","volume":"17","author":"Michallet M.","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_1_23_2","first-page":"465","article-title":"Peripheral blood stem cell transplantation in CLL patients in remission after fludarabine therapy. A feasibility study","volume":"17","author":"Meloni G.","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_1_24_2","first-page":"467","article-title":"Intensive radio\u2010chemotherapy with peripheral blood stem cell transplantation in young patients with chronic lymphocytic leukemia","volume":"10","author":"Bastion Y.","year":"1992","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"e_1_2_1_25_2","first-page":"1815","article-title":"Disease free status and absence of PCR detectable minimal residual disease suggest eradication of B\u2010CLL following autologous and allogeneic BMT","volume":"86","author":"Gribben JG","year":"1995","journal-title":"Blood"},{"issue":"1","key":"e_1_2_1_26_2","first-page":"1816","article-title":"Identification of chronic lymphocytic leukemia (CLL) progenitor cells","volume":"84","author":"Estrov Z.","year":"1994","journal-title":"Blood"},{"key":"e_1_2_1_27_2","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.1182\/blood.V89.12.4275","article-title":"Detection of trisomy 12 and Rb deletion in CF34+ cells of patients with B\u2010cell chronic lymphocytic leukemia","volume":"89","author":"Gahn B.","year":"1997","journal-title":"Blood"}],"container-title":["European Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0609.1998.tb01055.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0609.1998.tb01055.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T23:48:57Z","timestamp":1698536937000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0609.1998.tb01055.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,7]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1998,7]]}},"alternative-id":["10.1111\/j.1600-0609.1998.tb01055.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0609.1998.tb01055.x","archive":["Portico"],"relation":{},"ISSN":["0902-4441","1600-0609"],"issn-type":[{"value":"0902-4441","type":"print"},{"value":"1600-0609","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,7]]}}}